Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia

Published:1998-09 Issue:9 Volume:47 Page:1097-1104
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Knopp R.H.,Davidson M.,Goldberg A.C.,Kafonek S.D.,Kashyap M.,Sprecher D.,Superko H.R.,Jenkins S.,Marcovina S.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference33 articles.

1. Summary of the second report of the National Cholesterol Education Program expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II);National Cholesterol Education Program Expert Panel;JAMA,1993

2. Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio;Luria;Arch Intern Med,1988

3. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients;McKenney;JAMA,1994

4. Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid;Carlson;J Intern Med,1989

5. Fifteen year mortality on Coronary Drug Project patients: Long-term treatment with niacin;Canner;J Am Coll Cardiol,1986

Cited by 210 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Effect of Zinc and Niacin Powder Addition on some Physiological and Production Performance of Turkey;IOP Conference Series: Earth and Environmental Science;2023-04-01

2. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease, the Impact of Available Lipid-Lowering Medications on Lipoprotein(a): An Update on New Therapies;Endocrine Practice;2022-12

3. pH-Responsive Inorganic/Organic Nanohybrids System for Controlled Nicotinic Acid Drug Release;Molecules;2022-09-29

4. The Role of Niacin in the Management of Dyslipidemia;Dyslipidemia;2019-12-18

5. A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia;Clinical Pharmacology in Drug Development;2019-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3